Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:January 20, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:January 20, 2023Recruiting
Condition(s):Multiple MyelomaLast Updated:April 15, 2022Not yet recruiting
Condition(s):Multiple MyelomaLast Updated:July 8, 2022Recruiting
Condition(s):Multiple MyelomaLast Updated:February 8, 2021Completed
Condition(s):Multiple MyelomaLast Updated:December 23, 2022Recruiting
Condition(s):Relapsed/Refractory Multiple Myeloma(MM)Last Updated:September 24, 2021Terminated
Condition(s):Multiple MyelomaLast Updated:December 30, 2019Unknown status
Condition(s):Multiple Myeloma; Venous Thromboembolism; Arterial ThromboembolismLast Updated:November 3, 2022Recruiting
Condition(s):Multiple MyelomaLast Updated:October 6, 2022Terminated
Condition(s):Multiple MyelomaLast Updated:April 5, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.